| Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. CB Palatnik-de-Sousa, WR dos Santos, JC Franca-Silva, RT da Costa, ... The American journal of tropical medicine and hygiene 65 (5), 510-517, 2001 | 287 | 2001 |
| Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN) GP Borja-Cabrera, NNC Pontes, VO Da Silva, EP De Souza, WR Santos, ... Vaccine 20 (27-28), 3277-3284, 2002 | 228 | 2002 |
| A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN) VO da Silva, GP Borja-Cabrera, NNC Pontes, EP de Souza, KG Luz, ... Vaccine 19 (9-10), 1082-1092, 2000 | 196 | 2000 |
| Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune® in Brazilian endemic areas CB Palatnik-de-Sousa, I Silva-Antunes, A de Aguiar Morgado, I Menz, ... Vaccine 27 (27), 3505-3512, 2009 | 137 | 2009 |
| Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis WR Santos, VMF de Lima, EP de Souza, RR Bernardo, M Palatnik, ... Vaccine 21 (1-2), 30-43, 2002 | 136 | 2002 |
| Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine GP Borja-Cabrera, AC Mendes, EP de Souza, LYH Okada, ... Vaccine 22 (17-18), 2234-2243, 2004 | 135 | 2004 |
| Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani WR Santos, RR Bernardo, LMT Peçanha, M Palatnik, JP Parente, ... Vaccine 15 (9), 1024-1029, 1997 | 127 | 1997 |
| Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune® vaccine FN Santos, GP Borja-Cabrera, LM Miyashiro, J Grechi, AB Reis, ... Vaccine 25 (33), 6176-6190, 2007 | 99 | 2007 |
| occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors. AC Otero, VO da Silva, KG Luz, M Palatnik, C Pirmez, O Fernandes, ... The American journal of tropical medicine and hygiene 62 (1), 128-131, 2000 | 95 | 2000 |
| Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients. KG Luz, VO Da Silva, EM Gomes, FC Machado, MA Araujo, HE Fonseca, ... The American journal of tropical medicine and hygiene 57 (2), 168-171, 1997 | 91 | 1997 |
| Immunotherapy with the saponin enriched-Leishmune® vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis GP Borja-Cabrera, FN Santos, FB Santos, FAA Trivellato, JKA Kawasaki, ... Vaccine 28 (3), 597-603, 2010 | 80 | 2010 |
| Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis CB Palatnik-de-Sousa, EM Gomes, E Paraguai-de-Souza, M Palatnik, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 89 (4 …, 1995 | 74 | 1995 |
| Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis E Oliveira-Freitas, CP Casas, GP Borja-Cabrera, FN Santos, D Nico, ... Vaccine 24 (18), 3909-3920, 2006 | 73 | 2006 |
| Genetic relationships between Amerindian populations of Argentina AS Goicoechea, FR Carnese, C Dejean, SA Avena, TA Weimer, ... American Journal of Physical Anthropology: The Official Publication of the …, 2001 | 66 | 2001 |
| Improving methods for epidemiological control of canine visceral leishmaniasis based on a mathematical model. Impact on the incidence of the canine and human disease CB Palatnik-de-Sousa, LM Batista-de-Melo, GP Borja-Cabrera, M Palatnik, ... Anais da Academia Brasileira de Ciências 76, 583-593, 2004 | 63 | 2004 |
| Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine WR Santos, IA Aguiar, EP de Souza, VMF de Lima, M Palatnik, ... Vaccine 21 (32), 4668-4676, 2003 | 63 | 2003 |
| Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani EP de Souza, RR Bernardo, M Palatnik, CBP de Sousa Vaccine 19 (23-24), 3104-3115, 2001 | 62 | 2001 |
| Adaptive Immunity against Leishmania Nucleoside Hydrolase Maps Its C-Terminal Domain as the Target of the CD4+ T Cell–Driven Protective Response D Nico, C Claser, GP Borja-Cabrera, LR Travassos, M Palatnik, ... PLoS neglected tropical diseases 4 (11), e866, 2010 | 52 | 2010 |
| IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis. CO Mendes, EP Souza, GP Borja-Cabrera, LMM Batista, MA Santos, ... | 52 | 2003 |
| Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins CBP De Sousa, WR Santos, CP Casas, EP De Souza, LW Tinoco, ... Vaccine 22 (19), 2470-2479, 2004 | 46 | 2004 |
